Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

INTRODUCTION. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. METHODS. A post hoc analysis of the efficacy and tolerability...

Full description

Saved in:
Bibliographic Details
Main Authors: Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2013
Subjects:
Gastrointestinal Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556255/
https://ncbi.nlm.nih.gov/pubmed/23263288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0263
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items